WOOD LAUREN 4
4 · PDS Biotechnology Corp · Filed Jan 20, 2022
Insider Transaction Report
Form 4
WOOD LAUREN
Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-01-19+88,600→ 88,600 totalExercise: $6.28Exp: 2032-01-19→ Common Stock (88,600 underlying)
Footnotes (1)
- [F1]This option, representing a right to purchase a total of 88,600 shares of Common Stock, will become exercisable on January 19, 2023, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 19, 2026.